GlaxoSmithKline's 'Red Wine' Drug Trial Halted Over Safety Concerns
WSJ -- In a possible setback for scientists attempting to make drugs out of a substance found in red wine, GlaxoSmithKline PLC said a clinical trial of one drug in cancer patients has been halted due to safety concerns.